Few numbers on a botanical specification are as widely quoted and as widely misunderstood as the Drug-Extract Ratio. It appears as a clean fraction — 4:1, 10:1, 20:1 — and is read across the desk as a strength index, as though 10:1 were necessarily more than twice as concentrated as 4:1. In reality the ratio is an input-to-output description, not a content measurement, and its meaning collapses the moment the starting material, the solvent and the assay behind it are left unstated. This article unpacks what DER does and does not tell you, distinguishes native, ratio and standardised extracts, and sets out how to specify each so that the document and the drum agree.
What Drug-Extract Ratio actually describes
Drug-Extract Ratio (DER) is the ratio of the quantity of starting herbal material (the “drug”, in the pharmacopoeial sense of dried botanical raw material) to the quantity of extract produced from it. A DER of 4:1 means that, nominally, four kilograms of raw material yielded one kilogram of extract. It is a yield relationship, expressed mass-to-mass (w/w), and it says nothing directly about how much of any active constituent is present in that kilogram.
This matters because two materials with identical DER can carry very different amounts of the compounds you care about. The raw material differs in quality and active content from harvest to harvest; the solvent determines which constituents are pulled into the extract and which are left behind; and the drying and concentration steps determine what the final mass is composed of. DER fixes none of these. It is a useful descriptor of process intensity, but on its own it is not a measure of strength.
Genuine DER vs nominal DER
A genuine (or true) DER is the ratio that was actually achieved for a given lot, calculated from the real masses processed. A nominal DER is a label figure — a typical or target ratio for the product, often rounded and often presented as a range collapsed to a single number. Most “4:1” claims in commerce are nominal. The distinction is not pedantic: a nominal 4:1 might in practice span anywhere from roughly 3:1 to 6:1 across lots, depending on the variability of the raw material and the process. When a specification cites a single tidy ratio with no tolerance, assume it is nominal until the supplier confirms otherwise.
Native DER and the range that hides inside it
The native DER is the ratio of starting material to native extract — the extract before any excipient or carrier is added. It is the figure that genuinely reflects extraction intensity, because it concerns only plant-derived solids. Pharmacopoeial monographs frequently express it as a range (for example DER 3–6:1) precisely because biological starting material is not uniform. When a carrier is then blended in to standardise the final product or to improve handling, the labelled DER of the finished extract drifts away from the native DER. A product sold as “4:1” may be a higher native DER cut back with carrier, or a lower native DER concentrated and then diluted — and these arrive in your process very differently.
The practical consequence: ask for the native DER, not just the finished-product DER, and ask whether it is a single value or a range. The native figure, paired with a marker assay, is what lets QC reason about lot-to-lot equivalence.
Native, ratio and standardised extracts are not the same object
Three terms are routinely used as if interchangeable. They are not, and conflating them is the root of most specification disputes.
Native extract
A native extract is the extract as obtained from the plant after extraction and removal of solvent, with no added excipient. Its composition is whatever the solvent pulled from that raw material. A native extract has a native DER but is not, by itself, standardised to any target — its marker content is whatever it is for that lot.
Ratio extract
A ratio extract is specified by its DER and little else. “10:1 turmeric extract” is a ratio extract: it tells you the concentration step but leaves the active content floating. Ratio extracts are legitimate and useful — particularly for full-spectrum or traditional-use products where no single marker is meant to dominate — but they are controlled by process, not by content. If you buy on ratio alone, you are trusting the consistency of the supplier's raw material and process rather than verifying the output.
Standardised extract
A standardised extract is adjusted so that a defined constituent (or class of constituents) sits at a defined level, verified by assay — for example “Ginkgo biloba extract, 24% flavonol glycosides and 6% terpene lactones by HPLC”. Standardisation is a content guarantee, enforced lot to lot, usually by HPLC against authenticated reference standards. A standardised extract still has a DER, but the DER is now secondary: the marker percentage is the controlling specification.
Standardising to a marker vs to a class
Standardisation targets fall on a spectrum of specificity. Standardising to a single named molecule (e.g. withaferin A, or curcumin specifically) is the tightest and most expensive: it controls one compound against one reference standard. Standardising to a class (e.g. total withanolides, total curcuminoids, total ginsenosides) controls a family of related compounds summed together. The class figure is almost always higher and easier to hit, and it permits internal variation in the mix of family members so long as the total holds.
Both are valid, but they are not equivalent claims, and a spec that says only “5%” without saying “5% of what, summed how” is under-defined. R&D should decide whether the activity of interest tracks a single molecule or the whole class, and write the standardisation target accordingly. Procurement should never treat a class total and a specific-molecule figure as comparable line items.
Spiking, over-standardisation and integrity
Because standardisation is enforced by assay, there is a standing temptation to hit the number by the cheapest route rather than the most honest one. Three practices sit on a sliding scale from acceptable to adulteration, and the spec is the only thing that distinguishes them.
- Concentrating the native extract or blending lots to bring a naturally variable marker up to target — generally legitimate, because the marker still comes from the same botanical.
- Adding an isolated form of the marker compound (for example, synthetic or separately purified curcumin) to lift the assay value — “over-standardisation” or spiking. The number passes, but the extract no longer reflects the native phytochemical balance, and a class-blind single-marker assay will not catch it.
- Adding a cheaper plant rich in the same marker class, or undeclared isolated compounds, to reach the figure economically — adulteration, full stop, and a food-safety and regulatory exposure as much as a quality one.
The integrity concern is that a marker assay confirms the marker is present at the stated level; it does not confirm the marker arrived honestly. Defences are orthogonal to the assay: a fingerprint (HPTLC or full HPLC profile) to show the native constituent pattern is intact, ratio checks between co-occurring constituents that should track together in genuine material, and isotopic or origin testing where economically motivated adulteration is a known risk. A specification that asks for a marker percentage and a fingerprint is far harder to game than one that asks for a percentage alone.
Excipients, carriers and the actives that actually arrive
Most powdered botanical extracts are not pure native extract. To make a sticky, hygroscopic native solid into a free-flowing, dryable, dosable powder, a carrier is added before or during spray-drying — most commonly maltodextrin, sometimes gum arabic (acacia), occasionally silicon dioxide as a flow aid. The carrier is functionally necessary, but it dilutes the native material, and that dilution is precisely where the relationship between DER, marker percentage and what arrives gets confused.
Consider a native extract standardised at, say, 10% of a marker. If it is finished with 50% maltodextrin to aid drying, the finished powder now assays around 5% on the same marker — same native material, half the on-arrival concentration, because half the mass is carrier. The “effective ratio” of plant solids in the drum has likewise halved. A buyer comparing a 10% native-basis figure against a 5% finished-basis figure, without noticing the basis differs, will draw exactly the wrong conclusion.
| Basis quoted | Carrier in finished powder | Marker on the stated basis | Marker actually delivered per kg of powder |
|---|---|---|---|
| Native extract | 0% | 10% | 100 g |
| Finished powder | 30% maltodextrin | 7% | 70 g |
| Finished powder | 50% maltodextrin | 5% | 50 g |
| Finished powder | 60% gum arabic | 4% | 40 g |
The lesson is not that carriers are bad — they are usually essential and entirely declarable — but that the basis must be explicit. Always establish whether a marker percentage is quoted on the native extract or on the finished, carrier-loaded powder, and require the carrier identity and percentage on the specification and the COA. Without that, “actives on arrival” is a guess.
How to specify so the document and the drum agree
A tight botanical specification removes ambiguity at every point where two readings are possible. For an extract, that means pinning down the plant, the part, the process, the carrier and the assay — not just the headline ratio or percentage. Specify, in order:
- 1Botanical identity: genus, species and authority (e.g. Withania somnifera (L.) Dunal), plus the chemotype where relevant.
- 2Plant part used: root, leaf, aerial parts, fruit, rhizome — different parts give different constituent profiles and are a common source of substitution.
- 3Extraction solvent and process: e.g. water, hydroethanolic 50% v/v, supercritical CO₂ — the solvent defines what is in the extract before anything else.
- 4Native DER, with tolerance: a value or range (e.g. native DER 5–7:1), stated as native, not finished.
- 5Standardisation target, marker and basis: the constituent or class, the percentage, whether it is a single molecule or a class total, and whether the percentage is on the native extract or the finished powder (specify w/w).
- 6Analytical method: the assay used for the marker (e.g. by HPLC against authenticated reference standard) and, ideally, a required identity fingerprint (HPTLC or HPLC profile) to guard against spiking.
- 7Carrier / excipient identity and percentage: e.g. maltodextrin ≤ 40%, declared on the COA — so the effective ratio and actives-on-arrival are calculable.
- 8Limits and references: residual solvents, heavy metals, microbiology and pesticide limits against the relevant pharmacopoeial or regulatory reference, so the specification is enforceable, not merely descriptive.
A specification written this way lets QC verify equivalence between lots and between suppliers on a like-for-like basis, gives R&D a stable input to formulate against, and gives procurement defensible grounds for accepting or rejecting a lot. The ratio remains useful context — but it is now one controlled parameter among several, not a lone number doing work it was never designed to do.
Apply this to your sourcing
Share your specifications — we’ll respond within 24 hours.